| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HIV/AIDS in Asia.
|
Lancet
|
2004
|
4.45
|
|
2
|
An algorithm for tuberculosis screening and diagnosis in people with HIV.
|
N Engl J Med
|
2010
|
4.24
|
|
3
|
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.
|
PLoS One
|
2012
|
3.69
|
|
4
|
The TREAT Asia HIV Observational Database: baseline and retrospective data.
|
J Acquir Immune Defic Syndr
|
2005
|
3.18
|
|
5
|
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
|
PLoS Med
|
2005
|
3.17
|
|
6
|
Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.
|
Clin Infect Dis
|
2009
|
2.89
|
|
7
|
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.
|
J Acquir Immune Defic Syndr
|
2014
|
2.79
|
|
8
|
Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand.
|
AIDS
|
2005
|
2.58
|
|
9
|
Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003–2007.
|
J Acquir Immune Defic Syndr
|
2010
|
2.23
|
|
10
|
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.
|
Clin Infect Dis
|
2011
|
2.08
|
|
11
|
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial.
|
Lancet Infect Dis
|
2012
|
2.01
|
|
12
|
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial.
|
Lancet
|
2006
|
1.91
|
|
13
|
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
|
Int J Epidemiol
|
2010
|
1.76
|
|
14
|
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
|
Lancet
|
2014
|
1.73
|
|
15
|
One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
|
Transfusion
|
2009
|
1.68
|
|
16
|
Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.
|
AIDS
|
2004
|
1.62
|
|
17
|
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
|
Clin Infect Dis
|
2005
|
1.62
|
|
18
|
Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
|
Clin Infect Dis
|
2005
|
1.52
|
|
19
|
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
|
Antivir Ther
|
2012
|
1.48
|
|
20
|
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.
|
AIDS
|
2003
|
1.47
|
|
21
|
HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand.
|
AIDS Behav
|
2011
|
1.40
|
|
22
|
The invisibility of the HIV epidemic among men who have sex with men in Bangkok, Thailand.
|
AIDS
|
2005
|
1.39
|
|
23
|
Correlates of forced sex among populations of men who have sex with men in Thailand.
|
Arch Sex Behav
|
2009
|
1.36
|
|
24
|
HIV drug resistance transmission threshold survey in Bangkok, Thailand.
|
Antivir Ther
|
2008
|
1.35
|
|
25
|
Inconsistent condom use among young men who have sex with men, male sex workers, and transgenders in Thailand.
|
AIDS Educ Prev
|
2010
|
1.35
|
|
26
|
Health risk behaviors among HIV-infected youth in Bangkok, Thailand.
|
J Adolesc Health
|
2007
|
1.33
|
|
27
|
Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.
|
AIDS
|
2003
|
1.29
|
|
28
|
Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
|
AIDS
|
2005
|
1.28
|
|
29
|
Inconsistent condom use with steady and casual partners and associated factors among sexually-active men who have sex with men in Bangkok, Thailand.
|
AIDS Behav
|
2006
|
1.26
|
|
30
|
Incidence and characterization of acute HIV-1 infection in a high-risk Thai population.
|
J Acquir Immune Defic Syndr
|
2008
|
1.24
|
|
31
|
A novel acute HIV infection staging system based on 4th generation immunoassay.
|
Retrovirology
|
2013
|
1.24
|
|
32
|
Sexual behavior and risk factors for HIV infection among homosexual and bisexual men in Thailand.
|
AIDS Behav
|
2008
|
1.15
|
|
33
|
The quality of informed consent in a clinical research study in Thailand.
|
IRB
|
2005
|
1.13
|
|
34
|
Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence.
|
J Acquir Immune Defic Syndr
|
2013
|
1.13
|
|
35
|
Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting.
|
Int J STD AIDS
|
2008
|
1.12
|
|
36
|
Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.
|
BMC Infect Dis
|
2009
|
1.12
|
|
37
|
Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir.
|
J Acquir Immune Defic Syndr
|
2004
|
1.12
|
|
38
|
Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.
|
Antivir Ther
|
2005
|
1.09
|
|
39
|
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.
|
Antimicrob Agents Chemother
|
2006
|
1.08
|
|
40
|
HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.
|
AIDS Res Hum Retroviruses
|
2010
|
1.07
|
|
41
|
Acceptability of male circumcision for the prevention of HIV among high-risk heterosexual men in Thailand.
|
Sex Transm Dis
|
2010
|
1.05
|
|
42
|
Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.
|
AIDS
|
2011
|
0.99
|
|
43
|
Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection.
|
AIDS
|
2015
|
0.99
|
|
44
|
Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
|
BMC Infect Dis
|
2010
|
0.97
|
|
45
|
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.
|
AIDS
|
2005
|
0.97
|
|
46
|
Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients.
|
AIDS
|
2012
|
0.96
|
|
47
|
Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD.
|
AIDS Res Treat
|
2012
|
0.95
|
|
48
|
Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.
|
Clin Infect Dis
|
2003
|
0.94
|
|
49
|
Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand.
|
J Antimicrob Chemother
|
2006
|
0.94
|
|
50
|
Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
|
Antivir Ther
|
2008
|
0.94
|
|
51
|
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
|
AIDS
|
2003
|
0.93
|
|
52
|
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
|
J Antimicrob Chemother
|
2005
|
0.93
|
|
53
|
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
|
J Acquir Immune Defic Syndr
|
2002
|
0.92
|
|
54
|
Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.
|
J Acquir Immune Defic Syndr
|
2015
|
0.92
|
|
55
|
Examining HIV infection among male sex workers in Bangkok, Thailand: a comparison of participants recruited at entertainment and street venues.
|
AIDS Educ Prev
|
2010
|
0.92
|
|
56
|
Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: an approach to improve accessibility for HIV management.
|
Asian Pac J Allergy Immunol
|
2007
|
0.91
|
|
57
|
High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.
|
J Med Assoc Thai
|
2006
|
0.90
|
|
58
|
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.
|
J Int AIDS Soc
|
2012
|
0.90
|
|
59
|
Factors associated with HIV testing history and returning for HIV test results among men who have sex with men in Thailand.
|
AIDS Behav
|
2011
|
0.89
|
|
60
|
Creation of a drug fund for post-clinical trial access to antiretrovirals.
|
Lancet
|
2004
|
0.89
|
|
61
|
Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries.
|
Curr Opin HIV AIDS
|
2011
|
0.88
|
|
62
|
A cross-cultural three-step process model for assessing motivational interviewing treatment fidelity in Thailand.
|
Health Educ Behav
|
2012
|
0.88
|
|
63
|
Dose-escalating study of the safety and pharmacokinetics of nelfinavir in HIV-exposed neonates.
|
J Acquir Immune Defic Syndr
|
2002
|
0.88
|
|
64
|
Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.
|
J Acquir Immune Defic Syndr
|
2003
|
0.88
|
|
65
|
Bloodstream infections among HIV-infected outpatients, Southeast Asia.
|
Emerg Infect Dis
|
2010
|
0.88
|
|
66
|
Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
|
AIDS Patient Care STDS
|
2014
|
0.87
|
|
67
|
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.
|
J Antimicrob Chemother
|
2008
|
0.87
|
|
68
|
Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients.
|
AIDS
|
2006
|
0.87
|
|
69
|
Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia.
|
PLoS One
|
2010
|
0.87
|
|
70
|
Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.
|
J Acquir Immune Defic Syndr
|
2013
|
0.86
|
|
71
|
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.
|
AIDS Res Ther
|
2008
|
0.85
|
|
72
|
Perceived dental needs and attitudes toward dental treatments in HIV-infected Thais.
|
AIDS Care
|
2012
|
0.84
|
|
73
|
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects.
|
J Acquir Immune Defic Syndr
|
2003
|
0.84
|
|
74
|
Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease.
|
J Neurol
|
2006
|
0.84
|
|
75
|
Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.
|
AIDS
|
2013
|
0.83
|
|
76
|
Motivational interviewing targeting risk behaviors for youth living with HIV in Thailand.
|
AIDS Behav
|
2013
|
0.83
|
|
77
|
Active voluntary counseling and testing with integrated CD4 count service can enhance early HIV testing and early CD4 count measurement: experiences from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.
|
J Acquir Immune Defic Syndr
|
2011
|
0.83
|
|
78
|
Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz.
|
J Infect Dis
|
2006
|
0.83
|
|
79
|
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.
|
J Acquir Immune Defic Syndr
|
2004
|
0.83
|
|
80
|
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
|
PLoS One
|
2011
|
0.83
|
|
81
|
HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand.
|
AIDS Res Ther
|
2012
|
0.83
|
|
82
|
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
|
Pharmacogenet Genomics
|
2006
|
0.82
|
|
83
|
Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.
|
Antivir Ther
|
2005
|
0.82
|
|
84
|
Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men.
|
PLoS One
|
2013
|
0.82
|
|
85
|
An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection.
|
Hum Vaccin
|
2010
|
0.82
|
|
86
|
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
|
J Acquir Immune Defic Syndr
|
2005
|
0.82
|
|
87
|
Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.
|
Antivir Ther
|
2009
|
0.82
|
|
88
|
Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
|
Vaccine
|
2011
|
0.81
|
|
89
|
Pharmacokinetics of lower doses of saquinavir soft-gel caps (800 and 1200 mg twice daily) boosted with itraconazole in HIV-1-positive patients.
|
Antivir Ther
|
2003
|
0.81
|
|
90
|
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.
|
Antivir Ther
|
2007
|
0.81
|
|
91
|
Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.
|
J Int Assoc Physicians AIDS Care (Chic)
|
2007
|
0.81
|
|
92
|
Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world.
|
Expert Rev Mol Diagn
|
2006
|
0.80
|
|
93
|
High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV.
|
AIDS
|
2013
|
0.80
|
|
94
|
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
|
J Antimicrob Chemother
|
2006
|
0.80
|
|
95
|
Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok.
|
Open Virol J
|
2012
|
0.80
|
|
96
|
Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand.
|
AIDS Res Hum Retroviruses
|
2011
|
0.79
|
|
97
|
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency.
|
AIDS Res Ther
|
2012
|
0.79
|
|
98
|
High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2015
|
0.79
|
|
99
|
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy.
|
J Acquir Immune Defic Syndr
|
2014
|
0.79
|
|
100
|
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
|
Antivir Ther
|
2006
|
0.78
|
|
101
|
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients.
|
Antivir Ther
|
2012
|
0.78
|
|
102
|
Long-term lopinavir/ritonavir monotherapy in HIV-infected children.
|
Pediatr Infect Dis J
|
2013
|
0.78
|
|
103
|
In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2003
|
0.77
|
|
104
|
Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.
|
AIDS Patient Care STDS
|
2015
|
0.77
|
|
105
|
Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients.
|
AIDS Res Hum Retroviruses
|
2013
|
0.76
|
|
106
|
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).
|
J Infect Dis
|
2006
|
0.76
|
|
107
|
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors.
|
AIDS Res Hum Retroviruses
|
2012
|
0.76
|
|
108
|
Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais.
|
AIDS Care
|
2014
|
0.76
|
|
109
|
Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E.
|
Clin Infect Dis
|
2004
|
0.76
|
|
110
|
HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.
|
PLoS One
|
2013
|
0.76
|
|
111
|
Elimination of Mother-to-Child Transmission of HIV - Thailand.
|
MMWR Morb Mortal Wkly Rep
|
2016
|
0.76
|
|
112
|
Motivational interviewing targeting risky sex in HIV-positive young Thai men who have sex with men.
|
Arch Sex Behav
|
2014
|
0.75
|
|
113
|
Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study.
|
J Acquir Immune Defic Syndr
|
2014
|
0.75
|
|
114
|
Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
115
|
Comparable performance of conventional and liquid-based cytology in diagnosing anal intraepithelial neoplasia in HIV-infected and -uninfected Thai men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2013
|
0.75
|
|
116
|
Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia.
|
J Acquir Immune Defic Syndr
|
2015
|
0.75
|
|
117
|
A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.
|
J Acquir Immune Defic Syndr
|
2014
|
0.75
|
|
118
|
Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific Region.
|
J Antivir Antiretrovir
|
2009
|
0.75
|
|
119
|
The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000-2014.
|
J Virus Erad
|
2017
|
0.75
|
|
120
|
Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.
|
AIDS Res Hum Retroviruses
|
2012
|
0.75
|
|
121
|
V-1 Immunitor.
|
HIV Clin Trials
|
2002
|
0.75
|
|
122
|
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice daily.
|
J Acquir Immune Defic Syndr
|
2012
|
0.75
|
|
123
|
Construction and immunogenicity study of a 297-bp humanized HIV V3 DNA of an approximated last common ancestor in mice.
|
Asian Pac J Allergy Immunol
|
2004
|
0.75
|
|
124
|
No effect of interleukin-2 on IgE levels given in addition to antiretroviral therapy in HIV-infected adults with CD4 >300 cells/mm3.
|
Asian Pac J Allergy Immunol
|
2005
|
0.75
|
|
125
|
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.
|
AIDS
|
2006
|
0.75
|
|
126
|
The HIV Netherlands Australia Thailand research collaboration: lessons from 7 years of clinical research.
|
AIDS
|
2004
|
0.75
|
|
127
|
The Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
128
|
An outcome based nutrition curriculum for counselors at HIV voluntary counseling and testing facilities in Vietnam.
|
Southeast Asian J Trop Med Public Health
|
2013
|
0.75
|
|
129
|
Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.
|
AIDS
|
2011
|
0.75
|
|
130
|
Beneficial effect of macrophage activating agent NK-4 on Thai HIV-infected patients.
|
Anticancer Res
|
2003
|
0.75
|
|
131
|
HIV care in 2003: a viewpoint.
|
IAPAC Mon
|
2003
|
0.75
|
|
132
|
Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy.
|
Asian Pac J Allergy Immunol
|
2002
|
0.75
|
|
133
|
Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
134
|
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
|
AIDS
|
2007
|
0.75
|
|
135
|
Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.
|
J Acquir Immune Defic Syndr
|
2010
|
0.75
|
|
136
|
Attitudes toward, and interest in, the test-and-treat strategy for HIV prevention among Thai men who have sex with men.
|
AIDS Care
|
2014
|
0.75
|
|
137
|
Henoch-Schönlein purpura and thrombocytopenia after planned antiretroviral treatment interruption in a Thai girl with HIV infection.
|
Int J Infect Dis
|
2008
|
0.75
|
|
138
|
Incidence and risk factors for non-nucleoside reverse transcriptase inhibitors (NNRTI)-related rash in Thai children with HIV infection.
|
J Med Assoc Thai
|
2007
|
0.75
|
|
139
|
Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV.
|
J Acquir Immune Defic Syndr
|
2012
|
0.75
|
|
140
|
Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries.
|
Expert Opin Investig Drugs
|
2002
|
0.75
|